Labeling antigen-specific CD4+ T cells with class II MHC oligomers

Journal of Immunological Methods

Volumn 268, Issue 1, 2002, Pages 51-69

  Cameron, Thomas O ^a   Norris, Philip J ^b   Patel, Alka ^c   Moulon, Corinne ^d   Rosenberg, Eric S ^b   Mellins, Elizabeth D ^e   Wedderburn, Lucy R ^c   Stern, Lawrence J ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d Dictagene   (Switzerland)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Avidity; Binding assay; Flow cytometry; Helper T cell; HLA DR; MHC tetramers; Multi valent binding; Receptor ligand interactions; T lymphocyte

Indexed keywords

BIOTIN; CYSTEINE; FLUORESCENT DYE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; OLIGOMER; PEPTIDE; STREPTAVIDIN; TETRAMER;

ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; BINDING AFFINITY; BINDING ASSAY; CHEMICAL MODIFICATION; ENZYME MODIFICATION; ESCHERICHIA COLI; EXPRESSION VECTOR; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INSECT CELL; METHODOLOGY; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN FOLDING; REVIEW; T LYMPHOCYTE;

ESCHERICHIA COLI; INSECTA;

EID: 0036801038     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(02)00200-4     Document Type: Article

References (57)

1. Altman J.D., Reay P.A., Davis M.M. Formation of functional peptide complexes of class II major histocompatibility complex proteins from subunits produced in Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 90:1993;10330-10334.
2. Altman J.D., Moss P.A.H., Goulder P.J.R., Barouch D.H., McHeyzer-Williams M.G., Bell J.I., McMichael A.J., Davis M.M. Phenotypic analysis of antigen-specific T lymphocytes. Science. 274:1996;94-96.
3. Appel H., Gauthier L., Pyrdol J., Wucherpfennig K.W. Kinetics of T-cell receptor binding by bivalent HLA-DR. Peptide complexes that activate antigen-specific human T-cells. J. Biol. Chem. 275:2000;312-321.
4. Benlagha K., Weiss A., Beavis A., Teyton L., Bendelac A. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 191:2000;1895-1903.
5. Boniface J.J., Rabinowitz J.D., Wulfing C., Hampl J., Reich Z., Altman J.D., Kantor R.M., Beeson C., McConnell H.M., Davis M.M. Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands. Immunity. 9:1998;459-466.
6. Bunch T.A., Grinblat Y., Goldstein L.S. Characterization and use of the Drosophila metallothionein promoter in cultured Drosophila melanogaster cells. Nucleic Acids Res. 16:1988;1043-1061.
7. Burrows G.G., Chang J.W., Bachinger H.P., Bourdette D.N., Offner H., Vandenbark A.A. Design, engineering and production of functional single-chain T cell receptor ligands. Protein Eng. 12:1999;771-778.
8. Cameron T.O., Cochran J.R., Yassine-Diab B., Sekaly R.P., Stern L.J. Cutting edge: detection of antigen-specific CD4+ T cells by HLA-DR1 oligomers is dependent on the T cell activation state. J. Immunol. 166:2001;741-745.
9. Chicz R.M., Urban R.G., Lane W.S., Gorga J.C., Stern L.J., Vignali D.A., Strominger J.L. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature. 358:1992;764-768.
10. Cochran J.R., Stern L.J. A diverse set of oligomeric class II MHC-peptide complexes for probing T cell receptor interactions. Chem. Biol. 7:2000;683-696.
11. Cochran J.R., Cameron T.O., Stern L.J. The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class II oligomers. Immunity. 12:2000;241-250.
12. Cochran J.R., Aivazian D., Cameron T.O., Stern L.J. Receptor clustering and transmembrane signaling in T cells. Trends Biochem. Sci. 26:2001;304-310.
13. Crawford F., Kozono H., White J., Marrack P., Kappler J. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity. 8:1998;675-682.
14. De Magistris M.T., Alexander J., Coggeshall M., Altman A., Gaeta F.C., Grey H.M., Sette A. Antigen analog - major histocompatibility complexes act as antagonists of the T cell receptor. Cell. 68:1992;625-634.
15. de Visser K.E., Cordaro T.A., Kioussis D., Haanen J.B., Schumacher T.N., Kruisbeek A.M. Tracing and characterization of the low-avidity self-specific T cell repertoire. Eur. J. Immunol. 30:2000;1458-1468.
16. Ding Y.-H., Baker B.M., Garboczi D.N., Biddison W.E., Wiley D.C. Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. Immunity. 11:1999;45-56.
17. Fahmy T.M., Bieler J.G., Edidin M., Schneck J.P. Increased TCR avidity after T cell activation: a mechanism for sensing low-density antigen. Immunity. 14:2001;135-143.
18. Frayser M., Sato A.K., Xu L., Stern L.J. Empty and peptide-loaded class II major histocompatibility complex proteins produced by expression in Escherichia coli and folding in vitro. Protein Expr. Purif. 15:1999;105-114.
19. Garboczi D.N., Hung D.T., Wiley D.C. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. U. S. A. 89:1992;3429-3433.
20. Garcia K.C., Degano M., Stanfield R.L., Brunmanr A., Jackson M.R., Peterson P.A., Teyton L., Wilson I.A. An alpha-beta T cell receptor structure at 2.5 angstrom and its orientation in the TCR-MHC complex. Science. 274:1996;209-219.
21. Gauthier L., Smith K.J., Pyrdol J., Kalandadze A., Strominger J.L., Wiley D.C., Wucherpfennig K.W. Expression and crystallization of the complex of HLA-DR2 (DRA, DRB1*1501) and an immunodominant peptide of human myelin basic protein. Proc. Natl. Acad. Sci. 95:1998;11828-11832.
22. Gorga J.C., Horejsi V., Johnson D.R., Raghupathy R., Strominger J.L. Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line. J. Biol. Chem. 262:1987;16087-16094.
23. Goulder P.J., Tang Y., Brander C., Betts M.R., Altfeld M., Annamalai K., Trocha A., He S., Rosenberg E.S., Ogg G., O'Callaghan C.A., Kalams S.A., McKinney R.E. Jr., Mayer K., Koup R.A., Pelton S.I., Burchett S.K., McIntosh K., Walker B.D. Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children. J. Exp. Med. 192:2000;1819-1832.
24. Hesse M.D., Karulin A.Y., Boehm B.O., Lehmann P.V., Tary-Lehmann M. A T cell clone's avidity is a function of its activation state. J. Immunol. 167:2001;1353-1361.
25. Hewitt C.R.A., Lamb J.R., Hayball J., Hill M., Owen M.J., O'Hehir R.W. Major histocompatibility complex independent claonal T cell anergy by direct interaction of Staphylococcus aureus Enterotoxin B with the T cell antigen receptor. J. Exp. Med. 175:1992;1493-1499.
26. Kozono H., White J., Clements J., Marrack P., Kappler J. Production of soluble MHC class II proteins with covalently bound single peptides. Nature. 369:1994;151-154.
27. Kozono H., Parker D., White J., Marrack P., Kappler J. Multiple binding sites for bacterial superantigens on soluble class II MHC molecules. Immunity. 3:1995;187-196.
28. Kwok W.W., Liu A.W., Novak E.J., Gebe J.A., Ettinger R.A., Nepom G.T., Reymond S.N., Koelle D.M. HLA-DQ tetramers identify epitope-specific T cells in peripheral blood of herpes simplex virus type 2-infected individuals: direct detection of immunodominant antigen-responsive cells. J. Immunol. 164:2000;4244-4249.
29. Lamb J.R., Eckels D.D., Lake P., Woody J.N., Green N. Human T-cell clones recognize chemically synthesized peptides of influenza heamagglutinin. Nature. 300:1982;66-69.
30. Li Y., Li H., Martin R., Mariuzza R.A. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins. J. Mol. Biol. 304:2000;177-188.
31. MacFerrin K.D., Terranova M.P., Schreiber S.L., Verdine G.L. Overproduction and dissection of proteins by the expression-cassette polymerase chain reaction. Proc. Natl. Acad. Sci. U. S. A. 87:1990;1937-1941.
32. Maini M.K., Wedderburn L.R., Hall F.C., Wack A., Casorati G., Beverley P.C. A comparison of two techniques for the molecular tracking of specific T-cell responses; CD4+ human T-cell clones persist in a stable hierarchy but at a lower frequency than clones in the CD8+ population. Immunology. 94:1998;529-535.
33. Margulies D.H. TCR avidity: it's not how strong you make it, it's how you make it strong. Nat. Immunol. 2:2001;669-670.
34. Meyer A.L., Trollmo C., Crawford F., Marrack P., Steere A.C., Huber B.T., Kappler J., Hafler D.A. Direct enumeration of Borrelia-reactive CD4 T cells ex vivo by using MHC class II tetramers. Proc. Natl. Acad. Sci. U. S. A. 97:2000;11433-11438.
35. Moser J.M., Altman J.D., Lukacher A.E. Antiviral CD8+ T cell responses in neonatal mice: susceptibility to polyoma virus-induced tumors is associated with lack of cytotoxic function by viral antigen-specific T cells. J. Exp. Med. 193:2001;595-606.
36. Moulon C., Wild D., Dormoy A., Weltzien H.U. MHC-dependent and -independent activation of human nickel-specific CD8+ cytotoxic T cells from allergic donors. J. Invest. Dermatol. 111:1998;360-366.
37. Nagai K., Thogersen H.C. Synthesis and sequence-specific proteolysis of hybrid proteins produced in Escherichia coli. Methods Enzymol. 153:1987;461-481.
38. Norris P.J., Sumaroka M., Brander C., Moffett H.F., Boswell S.L., Nguyen T., Sykulev Y., Walker B.D., Rosenberg E.S. Multiple effector functions mediated by human immunodeficiency virus-specific cd4(+) t-cell clones. J. Virol. 75:2001;9771-9779.
39. Novak E.J., Liu A.W., Nepom G.T., Kwok W.W. MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen. J. Clin. Invest. 104:1999;R63-R67.
40. Perelson A.S., Delisi C. Receptor clustering on a cell surface: I. Theory of receptor crosslinking by ligands bearing two chemically identical functional groups. Math. Biosci. 53:1980;1-39.
41. Reignat S., Webster G.J., Brown D., Ogg G.S., King A., Seneviratne S.L., Dusheiko G., Williams R., Maini M.K., Bertoletti A. Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J. Exp. Med. 195:2002;1089-1101.
42. Rhode P.R., Burkhardt M., Jiao J., Siddiqui A.H., Huang G.P., Wong H.C. Single-chain MHC class II molecules induce T cell activation and apoptosis. J. Immunol. 157:1996;4885-4891.
43. Robbins P.A., Rota P.A., Shapiro S.Z. A broad cytotoxic T lymphocyte response to influenza type B virus presented by multiple HLA molecules. Int. Immunol. 9:1997;815-823.
44. Savage P.A., Boniface J.J., Davis M.M. A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity. 10:1999;485-492.
45. Schatz P.J. Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli. Biotechnology (NY). 11:1993;1138-1143.
46. Scott C.A., Garcia K.C., Carbone F.R., Wilson I.A., Teyton L. Role of chain pairing for the production of functional soluble IA major histocompatibility complex class II molecules. J. Exp. Med. 183:1996;2087-2095.
47. Seth A., Stern L.J., Ottenhoff T.H., Engel I., Owen M.J., Lamb J.R., Klausner R.D., Wiley D.C. Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro. Nature. 369:1994;324-327.
48. Slifka M.K., Whitton J.L. Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR. Nat. Immunol. 2:2001;711-717.
49. Sloan V.S., Cameron P., Porter G., Gammon M., Amaya M., Mellins E., Zaller D.M. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature. 375:1995;802-806.
50. Spencer J.V., Braciale T.J. Incomplete CD8(+) T lymphocyte differentiation as a mechanism for subdominant cytotoxic T lymphocyte responses to a viral antigen. J. Exp. Med. 191:2000;1687-1698.
51. Stern L.J., Wiley D.C. The human class II MHC protein HLA-DR1 assembles as empty αβ heterodimers in the absence of antigenic peptide. Cell. 68:1992;465-477.
52. Stone J.D., Cochran J.R., Stern L.J. T-cell activation by soluble MHC oligomers can be described by a two-parameter binding model. Biophys. J. 2001;81.
53. Stratmann T., Apostolopoulos V., Mallet-Designe V., Corper A.L., Scott C.A., Wilson I.A., Kang A.S., Teyton L. The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder. J. Immunol. 165:2000;3214-3225.
54. Wedderburn L.R., Searle S.J., Rees A.R., Lamb J.R., Owen M.J. Mapping T cell recognition: the identification of a T cell receptor residue critical to the specific interaction with an influenza hemagglutinin peptide. Eur. J. Immunol. 25:1995;1654-1662.
55. Welsh R.M. Assessing CD8 T cell number and dysfunction in the presence of antigen. J. Exp. Med. 193:2001;F19-F22.
56. Whelan J.A., Dunbar P.R., Price D.A., Purbhoo M.A., Lechner F., Ogg G.S., Griffiths G., Phillips R.E., Cerundolo V., Sewell A.K. Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent. J. Immunol. 163:1999;4342-4348.
57. Willcox B.E., Gao G.F., Wyer J.R., Ladbury J.E., Bell J.I., Jakobsen B.K., van der Merwe P.A. TCR binding to peptide-MHC stabilizes a flexible recognition interface. Immunity. 10:1999;357-365.